PAI Pharma Acquires Nexus Pharmaceuticals, Expanding Portfolio of Sterile Injectable Products
PAI Pharma acquired Nexus Pharmaceuticals, adding over 20 hospital injectable products to its portfolio and expanding its presence in sterile injectable and hospital-focused pharmaceutical markets.
Why it matters. PAI Pharma and Nexus Pharmaceuticals are strengthening their offerings in critical care and oncology, potentially improving patient access to essential medicines.